Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05492682
Title START: Safety and Anti-Tumor Activity of PeptiCRAd-1 in Treatment of Cancer
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Valo Therapeutics Oy
Indications
Therapies
Age Groups: adult | senior
Covered Countries DEU

Facility Status City State Zip Country Details
Krankenhaus Nordwest RECRUITING Frankfurt Germany Details
National Center for Tumor Diseases RECRUITING Heidelberg Germany Details
Universitätsklinikum Tübingen RECRUITING Tübingen Germany Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field